Journal article icon

Journal article

Understanding structured medication reviews delivered by clinical pharmacists in primary care in England: a national cross-sectional survey

Abstract:
ObjectivesThis study explored how Structured Medication Reviews (SMRs) are being undertaken and the challenges to their successful implementation and sustainability.DesignA cross-sectional mixed methods online survey.SettingPrimary care in England.Participants120 clinical pharmacists with experience in conducting SMRs in primary care.ResultsSurvey responses were received from clinical pharmacists working in 15 different regions. The majority were independent prescribers (62%, n=74), and most were employed by Primary Care Networks (65%, n=78), delivering SMRs for one or more general practices. 61% (n=73) had completed, or were currently enrolled in, the approved training pathway. Patient selection was largely driven by the primary care contract specification: care home residents, patients with polypharmacy, patients on medicines commonly associated with medication errors, patients with severe frailty and/or patients using potentially addictive pain management medication. Only 26% (n=36) of respondents reported providing patients with information in advance. The majority of SMRs were undertaken remotely by telephone and were 21-30 min in length. Much variation was reported in approaches to conducting SMRs, with SMRs in care homes being deemed the most challenging due to additional complexities involved. Challenges included not having sufficient time to prepare adequately, address complex polypharmacy and complete follow-up work generated by SMRs, issues relating to organisational support, competing national priorities and lack of 'buy-in' from some patients and General Practitioners.ConclusionsThese results offer insights into the role being played by the clinical pharmacy workforce in a new country-wide initiative to improve the quality and safety of care for patients taking multiple medicines. Better patient preparation and trust, alongside continuing professional development, more support and oversight for clinical pharmacists conducting SMRs, could lead to more efficient medication reviews. However, a formal evaluation of the potential of SMRs to optimise safe medicines use for patients in England is now warranted.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.1136/bmjopen-2024-097012

Authors

More by this author
Institution:
University of Oxford
Role:
Author
More by this author
Institution:
University of Oxford
Role:
Author
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0001-6544-8066
More by this author
Institution:
University of Oxford
Role:
Author
More by this author
Role:
Author
ORCID:
0000-0002-7526-3038


Publisher:
BMJ Publishing Group
Journal:
BMJ Open More from this journal
Volume:
15
Issue:
9
Pages:
e097012
Publication date:
2025-09-30
Acceptance date:
2025-09-02
DOI:
EISSN:
2044-6055
ISSN:
2044-6055
Pmid:
41033757


Language:
English
Keywords:
Pubs id:
2297296
Local pid:
pubs:2297296
Source identifiers:
3362523
Deposit date:
2025-10-11
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP